Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.010.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -84.61% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -84.61% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -85.51% | -- | |||
| SG&A Expenses | 55.37% | 68.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.11% | 58.96% | |||
| Operating Income | -37.12% | -45.89% | |||
| Income Before Tax | -49.73% | -46.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -49.73% | -46.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -49.73% | -46.02% | |||
| EBIT | -37.12% | -45.89% | |||
| EBITDA | -37.07% | -45.91% | |||
| EPS Basic | -21.86% | -32.85% | |||
| Normalized Basic EPS | -21.83% | -32.90% | |||
| EPS Diluted | -21.86% | -32.85% | |||
| Normalized Diluted EPS | -21.83% | -32.90% | |||
| Average Basic Shares Outstanding | 22.87% | 9.89% | |||
| Average Diluted Shares Outstanding | 22.87% | 9.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||